Recipharm Advanced Bio

Stockholm, SE
AAV Lentiviral Cell Therapy
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-02
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (1) ○ EMA GMP ○ MHRA GMP

Quick Facts: Recipharm Advanced Bio

Signal Score
63.0/100 (as of 2026-04-02)
Quality Compliance
Assessment pending
Headquarters
Stockholm, SE
Modalities
AAV, Lentiviral, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: Recipharm
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Recipharm
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Stockholm, SE
Modalities: AAV, Lentiviral, Cell Therapy
Capacity assessment: 58.0/100
Sites: Stockholm, SE
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press1 articles
1 manufacturing site: Stockholm, SE
Modalities: AAV, Lentiviral, Cell Therapy
Capacity assessment: 58.0/100

Recent News 1 articles

general 2026-03-23
Recipharm shutters Boxborough facility, cuts local workforce 40% - Worcester Business Journal
Recipharm shutters Boxborough facility, cuts local workforce 40%  Worcester Business Journal
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 80.2
CAR-T, Cell Therapy, AAV, Lentiviral
OmniaBio
Hamilton, ON
Signal Score: 79.5
AAV, Lentiviral, CAR-T, Cell Therapy
Lonza
Basel, Switzerland
Signal Score: 78.6
AAV, Lentiviral, Cell Therapy, mRNA
NecstGen
Leiden, NL
Signal Score: 78.1
AAV, Lentiviral, Cell Therapy